Showing 1 - 12 results of 12 for search 'Gordon C. Jayson', query time: 0.05s
Refine Results
-
1
Profiling Heparan Sulfate Proteoglycans in Ovarian Carcinoma by Andrew R. Clamp, Gordon C. Jayson
Published 2005-01-01
Article -
2
-
3
Modular Synthesis of Heparin-Related Tetra-, Hexa- and Octasaccharides with Differential O-6 Protections: Programming for Regiodefined 6-O-Modifications by Marek Baráth, Steen U. Hansen, Charlotte E. Dalton, Gordon C. Jayson, Gavin J. Miller, John M. Gardiner
Published 2015-04-01
Article -
4
-
5
Synthetic Site-Selectively Mono-6-O-Sulfated Heparan Sulfate Dodecasaccharide Shows Anti-Angiogenic Properties In Vitro and Sensitizes Tumors to Cisplatin In Vivo. by Egle Avizienyte, Claire L Cole, Graham Rushton, Gavin J Miller, Antonella Bugatti, Marco Presta, John M Gardiner, Gordon C Jayson
Published 2016-01-01
Article -
6
-
7
Palliative home parenteral nutrition in patients with ovarian cancer and malignant bowel obstruction: experiences of women and family caregivers by Anne Marie Sowerbutts, Simon Lal, Jana Sremanakova, Andrew R. Clamp, Gordon C. Jayson, Antje Teubner, Lisa Hardy, Chris Todd, Anne-Marie Raftery, Eileen Sutton, Robert D. Morgan, Alexander J. Vickers, Sorrel Burden
Published 2019-12-01
Article -
8
Effect of oxaliplatin plus 5-fluorouracil or capecitabine on circulating and imaging biomarkers in patients with metastatic colorectal cancer: a prospective biomarker study by Reem D. Mahmood, Danielle Shaw, Tine Descamps, Cong Zhou, Robert D. Morgan, Saifee Mullamitha, Mark Saunders, Nerissa Mescallado, Alison Backen, Karen Morris, Ross A. Little, Susan Cheung, Yvonne Watson, James P. B. O’Connor, Alan Jackson, Geoff J. M. Parker, Caroline Dive, Gordon C. Jayson
Published 2021-04-01
Article -
9
The VALTIVE1 study protocol: a study for the validation of Tie2 as the first tumour vascular response biomarker for VEGF inhibitors by Margherita Carucci, Andrew Clamp, Cong Zhou, Chris Hurt, Rosalind Glasspool, Phillip J. Monaghan, Sally Thirkettle, Michael Wheatley, Madia Mahmood, Monica Narasimham, Tracy Cox, Hilary Morrison, Susan Campbell, Annmarie Nelson, Daniella Holland-Hart, Noreen Hopewell-Kelly, Abin Thomas, Catharine Porter, Magdalena Slusarczyk, Alys Irving, Caroline Dive, Richard Adams, Gordon C. Jayson
Published 2024-10-01
Article -
10
Psychosexual Morbidity in Women With Ovarian Cancer: Evaluation by Germline BRCA Gene Mutational Status by Chloe A. Logue, MBChB, MRes, Julia Pugh, BNurs (hons), MSc, PGDip, Philip Foden, BSc, MSc, Reem D. Mahmood, MBChB, MRCP, Robert D. Morgan, MBBS, Claire Mitchell, MBBS, MRCP, PhD, Jurjees Hasan, MSc, MD, FRCP, Andrew R. Clamp, MA, BMBCh, PhD, Gordon C. Jayson, PhD, FRCP
Published 2022-02-01
Article -
11
A living biobank of ovarian cancer ex vivo models reveals profound mitotic heterogeneity by Louisa Nelson, Anthony Tighe, Anya Golder, Samantha Littler, Bjorn Bakker, Daniela Moralli, Syed Murtuza Baker, Ian J. Donaldson, Diana C. J. Spierings, René Wardenaar, Bethanie Neale, George J. Burghel, Brett Winter-Roach, Richard Edmondson, Andrew R. Clamp, Gordon C. Jayson, Sudha Desai, Catherine M. Green, Andy Hayes, Floris Foijer, Robert D. Morgan, Stephen S. Taylor
Published 2020-02-01
Article -
12
Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal cancer by Gordon C. Jayson, Cong Zhou, Alison Backen, Laura Horsley, Kalena Marti-Marti, Danielle Shaw, Nerissa Mescallado, Andrew Clamp, Mark P. Saunders, Juan W. Valle, Saifee Mullamitha, Mike Braun, Jurjees Hasan, Delyth McEntee, Kathryn Simpson, Ross A. Little, Yvonne Watson, Susan Cheung, Caleb Roberts, Linda Ashcroft, Prakash Manoharan, Stefan J. Scherer, Olivia del Puerto, Alan Jackson, James P. B. O’Connor, Geoff J. M. Parker, Caroline Dive
Published 2018-11-01
Article